tirzepatide non responders Pretty neat new retrospective study of GLP-1 users: users lose more weight on average than semaglutide users, as we expected. They're also less likely to have non-responders and late-responders Are YOU a Slow/Non-Responder to
Description
doi: 10.3390/nu12030813
The maintenance dose of tirzepatide is the amount you continue taking after reaching your goal weight
Molecular control of delta-opioid receptor signalling
Mild nausea often resolves within a couple of weeks, while some individuals may experience intermittent symptoms for a longer period
A healthcare professional will assess if its the right option for your needs
